申请人:Merck & Co., Inc.
公开号:EP1466603A2
公开(公告)日:2004-10-13
The present invention relates to compounds, pharmaceutically acceptable salts, and compositions thereof of general formula (I):
wherein Ar is aryl and heteroaryl; R1, R2, R3 and R4 are hydrido, alkyl, cyano, heteroaryl, hydroxy, amino, acylamino, halo, alkoxy, aryloxy, carboxyamido, alkenyl, cycloalkyl, heterocyclyl, acyl, acyloxy, carboalkoxy, carboxy, thio, sulfinyl, sulfonyl and sulfoxy; R5, R6, R7 and R8 are hydrido and lower alkyl, and Het is a nitrogen-containing heterocyclic ring.
本发明涉及通式(I)的化合物、药学上可接受的盐及其组合物:
其中 Ar 是芳基和杂芳基;R1、R2、R3 和 R4 是氢基、烷基、氰基、杂芳基、羟基、氨基、酰氨基、卤代、烷氧基、芳氧基、羧氨基、烯基、环烷基、杂环烷基、酰基、酰氧基、羧烷氧基、羧基、硫代、亚砜基、磺酰基和磺氧基;R5、R6、R7 和 R8 为水螅基和低级烷基,Het 为含氮杂环。